Published in Psychopharmacology (Berl) on January 20, 2009
Chromatin remodeling--a novel strategy to control excessive alcohol drinking. Transl Psychiatry (2013) 1.11
Adolescent rearing conditions influence the relationship between initial anxiety-like behavior and ethanol drinking in male Long Evans rats. Alcohol Clin Exp Res (2012) 1.06
Effects of prazosin, an α1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats. Alcohol Clin Exp Res (2011) 0.95
Specific and nonspecific effects of naltrexone on goal-directed and habitual models of alcohol seeking and drinking. Alcohol Clin Exp Res (2013) 0.91
The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation. Biol Psychiatry (2015) 0.87
Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters. Neuropharmacology (2009) 0.87
The clinical pharmacology of acamprosate. Br J Clin Pharmacol (2014) 0.86
Recruitment of a Neuronal Ensemble in the Central Nucleus of the Amygdala Is Required for Alcohol Dependence. J Neurosci (2016) 0.86
Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboons. Psychopharmacology (Berl) (2012) 0.84
Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking. Alcohol Clin Exp Res (2012) 0.84
Assessing behavioral control across reinforcer solutions on a fixed-ratio schedule of reinforcement in rats. Alcohol (2014) 0.84
Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin/sucrose fading, or extended access training. Psychopharmacology (Berl) (2014) 0.82
Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse. Psychopharmacology (Berl) (2014) 0.80
Alterations in ethanol seeking and self-administration following yohimbine in selectively bred alcohol-preferring (P) and high alcohol drinking (HAD-2) rats. Behav Brain Res (2012) 0.79
Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat. Psychopharmacology (Berl) (2015) 0.78
Acamprosate modulates experimental autoimmune encephalomyelitis. Inflammopharmacology (2011) 0.78
Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats. Alcohol (2011) 0.78
Effect of β3 adrenoceptor activation in the basolateral amygdala on ethanol seeking behaviors. Psychopharmacology (Berl) (2013) 0.77
The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking. Neuropsychopharmacology (2015) 0.76
Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model. Physiol Behav (2015) 0.76
Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety. J Neurodev Disord (2017) 0.76
Selective chemical genetic inhibition of protein kinase C epsilon reduces ethanol consumption in mice. Neuropharmacology (2016) 0.75
Chromatin remodeling: a new landscape to treat harmful alcohol-use disorders. Future Med Chem (2013) 0.75
Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats. Alcohol (2015) 0.75
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry (1992) 5.48
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry (2008) 4.91
Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry (1992) 3.55
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction (2004) 3.27
Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol Clin Exp Res (2004) 3.19
Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res (1986) 3.14
Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology (2007) 2.61
Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res (1996) 2.51
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther (2006) 2.44
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry (2007) 2.28
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol (2007) 2.18
Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci (1998) 2.12
The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res (2007) 1.99
United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol (2000) 1.82
Acamprosate in alcohol dependence: how does it work? Addiction (1995) 1.41
Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) (2006) 1.37
Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol (2001) 1.36
Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav Pharmacol (2008) 1.33
A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res (2007) 1.28
What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res (2007) 1.26
Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcohol Clin Exp Res (2006) 1.24
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Addiction (2006) 1.24
Effects of raclopride in the nucleus accumbens on ethanol seeking and consumption. Alcohol Clin Exp Res (2001) 1.22
Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol (1995) 1.21
Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci (1997) 1.19
Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction (2008) 1.15
A new assessment of the ability of oral ethanol to function as a reinforcing stimulus. Alcohol Clin Exp Res (2000) 1.15
Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. Alcohol Clin Exp Res (2007) 1.15
Separate measures of ethanol seeking and drinking in the rat: effects of remoxipride. Alcohol (2002) 1.15
Effects of acamprosate on ethanol-seeking and self-administration in the rat. Alcohol Clin Exp Res (2001) 1.14
Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology (1998) 1.13
The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology (2005) 1.12
Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone. Psychopharmacology (Berl) (2003) 1.12
Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. J Stud Alcohol Drugs (2008) 1.12
Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology (2003) 1.08
Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol Alcohol (2000) 1.07
The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat. Pharmacol Biochem Behav (2004) 1.06
Devaluation of ethanol reinforcement. Alcohol (2004) 1.06
A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav (1984) 1.05
The discriminative stimulus properties of self-administered ethanol are mediated by GABA(A) and NMDA receptors in rats. Psychopharmacology (Berl) (2001) 1.04
Breakpoint determination and ethanol self-administration using an across-session progressive ratio procedure in the rat. Alcohol Clin Exp Res (1999) 1.03
Opiates and alcohol self-administration in animals. J Clin Psychiatry (1995) 1.02
Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial. Alcohol Clin Exp Res (2008) 1.01
A comparison of the effects of 6-beta naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats. Pharmacol Biochem Behav (2002) 1.00
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol (2001) 1.00
Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res (2004) 0.97
Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res (1997) 0.95
The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Addict Biol (2005) 0.94
Effect of naloxone on appetitive and consummatory phases of ethanol self-administration. Alcohol Clin Exp Res (2001) 0.93
Measuring ethanol-seeking behavior: the effect of using repeated extinction trials. Alcohol (2001) 0.92
Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Clin Exp Res (1998) 0.91
Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system. Alcohol Alcohol (2005) 0.89
Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2007) 0.86
Naltrexone modifies the palatability of basic tastes and alcohol in outbred male rats. Alcohol (2002) 0.86
Self-administered ethanol as a discriminative stimulus in rats. Drug Alcohol Depend (2001) 0.85
Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate. Alcohol (1987) 0.83
Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst. J Psychoactive Drugs (2006) 0.81
Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat. Alcohol (2002) 0.81
Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice. Psychopharmacology (Berl) (1998) 0.77
Behavioral and neurotransmitter specific roles for the ventral tegmental area in reinforcer-seeking and intake. Alcohol Clin Exp Res (2012) 0.84